Cite
HARVARD Citation
Shalabi, R. et al. (2022). Haematopoietic stem cell transplant patients have a high initial failure rate to hepatitis B vaccination that can be overcome with subsequent vaccination series. British journal of haematology. pp. 1404-1407. [Online].